Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19


Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures.

Donohue JM, Normand SL, Horvitz-Lennon M, Men A, Berndt ER, Huskamp HA.

J Ment Health Policy Econ. 2016 Jun;19(2):69-78.


Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.

Harrold LR, Reed GW, Kremer JM, Curtis JR, Solomon DH, Hochberg MC, Kavanaugh A, Saunders KC, Shan Y, Spruill TM, Pappas DA, Greenberg JD.

Arthritis Res Ther. 2016 Apr 26;18:94. doi: 10.1186/s13075-016-0992-3.


Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Lo-Ciganic WH, Gellad WF, Huskamp HA, Choudhry NK, Chang CC, Zhang R, Jones BL, Guclu H, Richards-Shubik S, Donohue JM.

Med Care. 2016 Jul;54(7):725-32. doi: 10.1097/MLR.0000000000000549.


Evaluating possible confounding by prescriber in comparative effectiveness research.

Franklin JM, Schneeweiss S, Huybrechts KF, Glynn RJ.

Epidemiology. 2015 Mar;26(2):238-41. doi: 10.1097/EDE.0000000000000241.


Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics.

Marcum ZA, Driessen J, Thorpe CT, Donohue JM, Gellad WF.

Ann Pharmacother. 2015 Mar;49(3):285-92. doi: 10.1177/1060028014563951. Epub 2014 Dec 16.


Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort.

Fisher A, Bassett K, Wright JM, Brookhart MA, Freeman HJ, Dormuth CR.

BMJ Open. 2014 Sep 30;4(9):e005532. doi: 10.1136/bmjopen-2014-005532.


How quickly do physicians adopt new drugs? The case of second-generation antipsychotics.

Huskamp HA, O'Malley AJ, Horvitz-Lennon M, Taub AL, Berndt ER, Donohue JM.

Psychiatr Serv. 2013 Apr 1;64(4):324-30. doi: 10.1176/


Confounding control in healthcare database research: challenges and potential approaches.

Brookhart MA, Stürmer T, Glynn RJ, Rassen J, Schneeweiss S.

Med Care. 2010 Jun;48(6 Suppl):S114-20. doi: 10.1097/MLR.0b013e3181dbebe3.


Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.

Curtis JR, Chen L, Harrold LR, Narongroeknawin P, Reed G, Solomon DH.

Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):101-7. doi: 10.1002/acr.20020.


Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention.

Rassen JA, Mittleman MA, Glynn RJ, Alan Brookhart M, Schneeweiss S.

Eur Heart J. 2010 Mar;31(5):561-72. doi: 10.1093/eurheartj/ehp437. Epub 2009 Nov 25.


Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships.

Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S.

J Clin Epidemiol. 2009 Dec;62(12):1226-32. doi: 10.1016/j.jclinepi.2008.12.005. Epub 2009 Apr 8.


Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.

Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S.

J Clin Epidemiol. 2009 Dec;62(12):1233-41. doi: 10.1016/j.jclinepi.2008.12.006. Epub 2009 Apr 5.


Patient and physician predictors of post-fracture osteoporosis management.

Block AE, Solomon DH, Cadarette SM, Mogun H, Choudhry NK.

J Gen Intern Med. 2008 Sep;23(9):1447-51. doi: 10.1007/s11606-008-0697-7. Epub 2008 Jun 27.


Use of recommended medications after myocardial infarction in Austria.

Winkelmayer WC, Bucsics AE, Schautzer A, Wieninger P, Pogantsch M; Pharmacoeconomics Advisory Council of the Austrian Sickness Funds.

Eur J Epidemiol. 2008;23(2):153-62. Epub 2007 Dec 7.


Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors.

Anning PB, Coles B, Morton J, Wang H, Uddin J, Morrow JD, Dey SK, Marnett LJ, O'Donnell VB.

Blood. 2006 Dec 15;108(13):4059-62. Epub 2006 Aug 24.


Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.

Brookhart MA, Wang PS, Solomon DH, Schneeweiss S.

Epidemiology. 2006 May;17(3):268-75.


Age and rising rates of cyclooxygenase-2 inhibitor use. Results from a national survey.

Steinman MA, McQuaid KR, Covinsky KE.

J Gen Intern Med. 2006 Mar;21(3):245-50. Epub 2006 Feb 22.


Improving ambulatory prescribing safety with a handheld decision support system: a randomized controlled trial.

Berner ES, Houston TK, Ray MN, Allison JJ, Heudebert GR, Chatham WW, Kennedy JI Jr, Glandon GL, Norton PA, Crawford MA, Maisiak RS.

J Am Med Inform Assoc. 2006 Mar-Apr;13(2):171-9. Epub 2005 Dec 15.

Supplemental Content

Support Center